Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Transfus Clin Biol ; 25(1): 14-18, 2018 Feb.
Article in French | MEDLINE | ID: mdl-29199112

ABSTRACT

AIM: Our objectives were to assess the management of patients with major thalassemia and identify the various complications and monitoring means. PATIENTS AND METHODS: A retrospective study was conducted on 26 ß-thalassemic patients in the department of paediatrics, Hédi Chaker hospital, Sfax, Tunisia during a period of 25 years (from 1 January 1990 to 31 December 2014). RESULTS: The mean age of the beginning of transfusion was 11.5 months. That was with phenotyped red blood cells but not leukodepleted blood. Twenty-three patients received chelation. Before 2001, all patients received deferoxamine, poor adherence to this treatment was observed in 66% of cases. It was replaced by deferiprone since 2006 and deferasirox since 2009. A combination of 2 or 3 chelators was indicated for four patients. A total splenectomy was performed in 10 cases patients; it was due to hypersplenism. The bone marrow transplant was performed for one patient at the age of 9 year but it was rejected. Many complications were detected: endocrine complications (19 cases), immune complications (9 cases), gallbladder stones (5 cases), cardiac complications (4 cases), osteoporosis (3 cases), infectious complications (3 cases) and thromboembolic complications (2 cases). We noted some side effects related to chelation therapy in twelve cases. Four patients were dead. CONCLUSION: Improving the medical care of homozygous ß-thalassemic children requires adherence to transfusion regimen and chelation therapy. Bone marrow transplantation remains the only possible curative therapy, which must be promoted in our country.


Subject(s)
beta-Thalassemia/therapy , Blood Grouping and Crossmatching/statistics & numerical data , Blood Transfusion/statistics & numerical data , Chelation Therapy/adverse effects , Chelation Therapy/statistics & numerical data , Child, Preschool , Combined Modality Therapy , Disease Management , Female , Hospital Departments , Hospitals, Urban/statistics & numerical data , Humans , Infant , Iron Chelating Agents/adverse effects , Iron Chelating Agents/therapeutic use , Leukocyte Reduction Procedures/statistics & numerical data , Male , Pediatrics , Retrospective Studies , Splenectomy/statistics & numerical data , Transfusion Reaction , Tunisia , beta-Thalassemia/drug therapy
2.
Ann Fr Anesth Reanim ; 30(11): 844-7, 2011 Nov.
Article in French | MEDLINE | ID: mdl-21978480

ABSTRACT

We report the case of a 26-year-old patient who was victim of severe head trauma following a trafic road accident. Two days after trauma, she had fever, pancytopenia and multi-organ failure. The haemophagocytic lymphohistiocytosis syndrome was suspected. This diagnosis was confirmed by biologic findings (elevated serum levels of ferritin and triglycerid) and histological findings (examination of bone marrow smears showing histiocytes phagocytosing blood cells). The evolution was unfavorable despite of corticotherapy and symptomatic measures.


Subject(s)
Craniocerebral Trauma/complications , Lymphohistiocytosis, Hemophagocytic/complications , Multiple Organ Failure/etiology , Accidents, Traffic , Adrenal Cortex Hormones/therapeutic use , Adult , Bone Marrow/pathology , Craniocerebral Trauma/surgery , Fatal Outcome , Female , Ferritins/blood , Humans , Leukocyte Count , Lymphohistiocytosis, Hemophagocytic/pathology , Neurosurgical Procedures , Pancytopenia/complications , Platelet Count , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...